Interrupted BCG vaccination is a major threat to global child health
Lancet Respir Med
.
2016 Apr;4(4):251-3.
doi: 10.1016/S2213-2600(16)00099-0.
Epub 2016 Mar 23.
Authors
Ben J Marais
1
,
James A Seddon
2
,
Anne K Detjen
3
,
Marieke J van der Werf
4
,
Malgorzata Grzemska
5
,
Anneke C Hesseling
6
,
Nigel Curtis
7
,
Stephen M Graham
7
;
WHO Child TB Subgroup
Affiliations
1
The Children's Hospital at Westmead, University of Sydney, Sydney, NSW 2145, Australia. Electronic address:
[email protected]
.
2
Department of Paediatrics, Imperial College London, London, UK.
3
United Nations Children's Fund (UNICEF), New York, NY, USA.
4
European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
5
WHO TB Programme, Geneva, Switzerland.
6
Desmond Tutu Centre Tuberculosis Centre, Stellenbosch University, Tygerberg, South Africa.
7
The University of Melbourne Department of Paediatrics and Murdoch Childrens Research Institute, Royal Children's Hospital, Australia.
PMID:
27016867
DOI:
10.1016/S2213-2600(16)00099-0
No abstract available
Publication types
Review
MeSH terms
BCG Vaccine / supply & distribution*
BCG Vaccine / therapeutic use
Child
Child Health*
Child, Preschool
Global Health*
Humans
Infant
Tuberculosis / prevention & control*
Vaccination*
Substances
BCG Vaccine
Grants and funding
001/WHO_/World Health Organization/International